Click here to get full coverage on How do insiders feel about MNMD - 2025 Dividend Review & AI Enhanced Trading Alerts - thegnnews.com

How do insiders feel about MNMD - 2025 Dividend Review & AI Enhanced Trading Alerts  thegnnews.com

How do insiders feel about MNMD - 2025 Dividend Review & AI Enhanced Trading Alerts - thegnnews.com

Click here to get full coverage on Mind Medicine (MindMed) Stock (MNMD) Opinions on Psychedelic Therapy Political Momentum - Nasdaq

Mind Medicine (MindMed) Stock (MNMD) Opinions on Psychedelic Therapy Political Momentum  Nasdaq

Mind Medicine (MindMed) Stock (MNMD) Opinions on Psychedelic Therapy Political Momentum - Nasdaq

Click here to get full coverage on All You Need to Know About Mind Medicine MindMed (MNMD) Rating Upgrade to Buy - Yahoo Finance

All You Need to Know About Mind Medicine MindMed (MNMD) Rating Upgrade to Buy  Yahoo Finance

All You Need to Know About Mind Medicine MindMed (MNMD) Rating Upgrade to Buy - Yahoo Finance

Click here to get full coverage on If You'd Invested $1,000 in Mind Medicine (MNMD) Stock 5 Years Ago, Here's How Much You'd Have Today - The Motley Fool

If You'd Invested $1,000 in Mind Medicine (MNMD) Stock 5 Years Ago, Here's How Much You'd Have Today  The Motley Fool

If You'd Invested $1,000 in Mind Medicine (MNMD) Stock 5 Years Ago, Here's How Much You'd Have Today - The Motley Fool

Click here to get full coverage on If You'd Invested $1,000 in Mind Medicine (MNMD) Stock 5 Years Ago, Here's How Much You'd Have Today - MSN

If You'd Invested $1,000 in Mind Medicine (MNMD) Stock 5 Years Ago, Here's How Much You'd Have Today  MSN

If You'd Invested $1,000 in Mind Medicine (MNMD) Stock 5 Years Ago, Here's How Much You'd Have Today - MSN

Click here to get full coverage on Mind Medicine (MindMed) Inc.'s (NASDAQ:MNMD) large institutional owners must be happy as stock continues to impress, up 17% over the past week - simplywall.st

Mind Medicine (MindMed) Inc.'s (NASDAQ:MNMD) large institutional owners must be happy as stock continues to impress, up 17% over the past week  simplywall.st

Mind Medicine (MindMed) Inc.'s (NASDAQ:MNMD) large institutional owners must be happy as stock continues to impress, up 17% over the past week - simplywall.st

Click here to get full coverage on Mind Medicine MNMD 2025Q2 Earnings Preview Upside Potential on Strong Analyst Ratings - AInvest

Mind Medicine MNMD 2025Q2 Earnings Preview Upside Potential on Strong Analyst Ratings  AInvest

Mind Medicine MNMD 2025Q2 Earnings Preview Upside Potential on Strong Analyst Ratings - AInvest

Click here to get full coverage on MindMed Announces New Employee Inducement Grants - Business Wire

MindMed Announces New Employee Inducement Grants  Business Wire

MindMed Announces New Employee Inducement Grants - Business Wire

Click here to get full coverage on How liquid is MNMD stock - Quarterly Profit Review & Stock Portfolio Risk Management - newsimpact.co.kr

How liquid is MNMD stock - Quarterly Profit Review & Stock Portfolio Risk Management  newsimpact.co.kr

How liquid is MNMD stock - Quarterly Profit Review & Stock Portfolio Risk Management - newsimpact.co.kr

Click here to get full coverage on 1 Reason to Buy MindMed (MNMD) - AOL.com

1 Reason to Buy MindMed (MNMD)  AOL.com

1 Reason to Buy MindMed (MNMD) - AOL.com

Click here to get full coverage on Mind Medicine: Heading In The Right Direction (NASDAQ:MNMD) - Seeking Alpha

Mind Medicine: Heading In The Right Direction (NASDAQ:MNMD)  Seeking Alpha

Mind Medicine: Heading In The Right Direction (NASDAQ:MNMD) - Seeking Alpha

Click here to get full coverage on 1 Reason to Buy MindMed (MNMD) - The Motley Fool

1 Reason to Buy MindMed (MNMD)  The Motley Fool

1 Reason to Buy MindMed (MNMD) - The Motley Fool

Click here to get full coverage on Mind Medicine (MindMed) Inc. (MNMD): Analysts See 285% Upside Potential - Yahoo Finance

Mind Medicine (MindMed) Inc. (MNMD): Analysts See 285% Upside Potential  Yahoo Finance

Mind Medicine (MindMed) Inc. (MNMD): Analysts See 285% Upside Potential - Yahoo Finance

Click here to get full coverage on Does Mind Medicine MindMed (MNMD) Have the Potential to Rally 279.84% as Wall Street Analysts Expect? - Nasdaq

Does Mind Medicine MindMed (MNMD) Have the Potential to Rally 279.84% as Wall Street Analysts Expect?  Nasdaq

Does Mind Medicine MindMed (MNMD) Have the Potential to Rally 279.84% as Wall Street Analysts Expect? - Nasdaq

Click here to get full coverage on Mind Medicine Inc (MNMD) Q2 2025 Earnings Call Highlights: Strategic Advances and Financial ... - Yahoo Finance

Mind Medicine Inc (MNMD) Q2 2025 Earnings Call Highlights: Strategic Advances and Financial ...  Yahoo Finance

Mind Medicine Inc (MNMD) Q2 2025 Earnings Call Highlights: Strategic Advances and Financial ... - Yahoo Finance

Click here to get full coverage on MindMed (MNMD) Q2 Net Loss Jumps 625% - Nasdaq

MindMed (MNMD) Q2 Net Loss Jumps 625%  Nasdaq

MindMed (MNMD) Q2 Net Loss Jumps 625% - Nasdaq

Click here to get full coverage on $MNMD stock is up 14% today. Here's what we see in our data. - Nasdaq

$MNMD stock is up 14% today. Here's what we see in our data.  Nasdaq

$MNMD stock is up 14% today. Here's what we see in our data. - Nasdaq

Click here to get full coverage on MindMed (MNMD) Q2 2025 Earnings Call Transcript - AOL.com

MindMed (MNMD) Q2 2025 Earnings Call Transcript  AOL.com

MindMed (MNMD) Q2 2025 Earnings Call Transcript - AOL.com

Click here to get full coverage on Mind Medicine (MindMed) Inc. (MNMD): Among the Best Psychedelic Stocks to Buy in 2025 - Yahoo Finance

Mind Medicine (MindMed) Inc. (MNMD): Among the Best Psychedelic Stocks to Buy in 2025  Yahoo Finance

Mind Medicine (MindMed) Inc. (MNMD): Among the Best Psychedelic Stocks to Buy in 2025 - Yahoo Finance

Click here to get full coverage on Mind Medicine: Initiating Hold Rating Due To Regulatory Challenges (NASDAQ:MNMD) - Seeking Alpha

Mind Medicine: Initiating Hold Rating Due To Regulatory Challenges (NASDAQ:MNMD)  Seeking Alpha

Mind Medicine: Initiating Hold Rating Due To Regulatory Challenges (NASDAQ:MNMD) - Seeking Alpha

Click here to get full coverage on Mind Medicine stock upgraded at Oppenheimer (MNMD:NASDAQ) - Seeking Alpha

Mind Medicine stock upgraded at Oppenheimer (MNMD:NASDAQ)  Seeking Alpha

Mind Medicine stock upgraded at Oppenheimer (MNMD:NASDAQ) - Seeking Alpha

Click here to get full coverage on MindMed to Report Second Quarter 2025 Financial Results on July 31, 2025 - Business Wire

MindMed to Report Second Quarter 2025 Financial Results on July 31, 2025  Business Wire

MindMed to Report Second Quarter 2025 Financial Results on July 31, 2025 - Business Wire

Click here to get full coverage on MindMed Strengthens Workforce with New Employee Inducement Grants - TipRanks

MindMed Strengthens Workforce with New Employee Inducement Grants  TipRanks

MindMed Strengthens Workforce with New Employee Inducement Grants - TipRanks

Click here to get full coverage on $MNMD stock is up 8% today. Here's what we see in our data. - Nasdaq

$MNMD stock is up 8% today. Here's what we see in our data.  Nasdaq

$MNMD stock is up 8% today. Here's what we see in our data. - Nasdaq

Click here to get full coverage on Unraveling the Sharp Drop in Mind Medicine (MNMD.O): A Technical and Order-Flow Deep Dive - AInvest

Unraveling the Sharp Drop in Mind Medicine (MNMD.O): A Technical and Order-Flow Deep Dive  AInvest

Unraveling the Sharp Drop in Mind Medicine (MNMD.O): A Technical and Order-Flow Deep Dive - AInvest

Click here to get full coverage on MIND MEDICINE Earnings Results: $MNMD Reports Quarterly Earnings - Nasdaq

MIND MEDICINE Earnings Results: $MNMD Reports Quarterly Earnings  Nasdaq

MIND MEDICINE Earnings Results: $MNMD Reports Quarterly Earnings - Nasdaq

Click here to get full coverage on MNMD Recovery Potential Based on Technical Tools - High Growth Low Risk Stock Selection Gets Analyst Nod - beatles.ru

MNMD Recovery Potential Based on Technical Tools - High Growth Low Risk Stock Selection Gets Analyst Nod  beatles.ru

MNMD Recovery Potential Based on Technical Tools - High Growth Low Risk Stock Selection Gets Analyst Nod - beatles.ru

Click here to get full coverage on Evercore ISI Group Initiates Coverage of Mind Medicine (MNMD) with Outperform Recommendation - Nasdaq

Evercore ISI Group Initiates Coverage of Mind Medicine (MNMD) with Outperform Recommendation  Nasdaq

Evercore ISI Group Initiates Coverage of Mind Medicine (MNMD) with Outperform Recommendation - Nasdaq

Click here to get full coverage on Mind Medicine: Strong Data, But Psychedelic Stigma Still Clouds Investor Confidence - Seeking Alpha

Mind Medicine: Strong Data, But Psychedelic Stigma Still Clouds Investor Confidence  Seeking Alpha

Mind Medicine: Strong Data, But Psychedelic Stigma Still Clouds Investor Confidence - Seeking Alpha

Click here to get full coverage on Mind Medicine (MindMed) Inc.'s (NASDAQ:MNMD) market cap touched US$601m last week, benefiting both retail investors who own 41% as well as institutions - Yahoo Finance

Mind Medicine (MindMed) Inc.'s (NASDAQ:MNMD) market cap touched US$601m last week, benefiting both retail investors who own 41% as well as institutions  Yahoo Finance

Mind Medicine (MindMed) Inc.'s (NASDAQ:MNMD) market cap touched US$601m last week, benefiting both retail investors who own 41% as well as institutions - Yahoo Finance

Click here to get full coverage on Mind Medicine (MindMed) (NASDAQ:MNMD) Earns Outperform Rating from Analysts at Oppenheimer - MarketBeat

Mind Medicine (MindMed) (NASDAQ:MNMD) Earns Outperform Rating from Analysts at Oppenheimer  MarketBeat

Mind Medicine (MindMed) (NASDAQ:MNMD) Earns Outperform Rating from Analysts at Oppenheimer - MarketBeat

Click here to get full coverage on Mind Medicine’s (MNMD) Recent Achievements Boosting Stock - TipRanks

Mind Medicine’s (MNMD) Recent Achievements Boosting Stock  TipRanks

Mind Medicine’s (MNMD) Recent Achievements Boosting Stock - TipRanks

Click here to get full coverage on Is Mind Medicine (MNMD) the Best Multibagger Stock to Buy Heading into 2025? - Yahoo Finance

Is Mind Medicine (MNMD) the Best Multibagger Stock to Buy Heading into 2025?  Yahoo Finance

Is Mind Medicine (MNMD) the Best Multibagger Stock to Buy Heading into 2025? - Yahoo Finance

Click here to get full coverage on Chardan Capital Maintains 'Buy' Rating and $20 Price Target for Mind Medicine (MNMD) - AInvest

Chardan Capital Maintains 'Buy' Rating and $20 Price Target for Mind Medicine (MNMD)  AInvest

Chardan Capital Maintains 'Buy' Rating and $20 Price Target for Mind Medicine (MNMD) - AInvest

Click here to get full coverage on MindMed Taps Former Jazz Pharma Executive to Lead MM120 Anxiety Drug Launch - Stock Titan

MindMed Taps Former Jazz Pharma Executive to Lead MM120 Anxiety Drug Launch  Stock Titan

MindMed Taps Former Jazz Pharma Executive to Lead MM120 Anxiety Drug Launch - Stock Titan

Click here to get full coverage on MindMed to Present at the 2025 RBC Capital Markets Global Healthcare Conference - Business Wire

MindMed to Present at the 2025 RBC Capital Markets Global Healthcare Conference  Business Wire

MindMed to Present at the 2025 RBC Capital Markets Global Healthcare Conference - Business Wire

Click here to get full coverage on MindMed Reports Q2 2025 Financial Results and Business Updates - Business Wire

MindMed Reports Q2 2025 Financial Results and Business Updates  Business Wire

MindMed Reports Q2 2025 Financial Results and Business Updates - Business Wire

Click here to get full coverage on (MNMD) Trading Signals - news.stocktradersdaily.com

(MNMD) Trading Signals  news.stocktradersdaily.com

(MNMD) Trading Signals - news.stocktradersdaily.com

Click here to get full coverage on MNMD stock touches 52-week low at $5.03 amid market challenges - Investing.com

MNMD stock touches 52-week low at $5.03 amid market challenges  Investing.com

MNMD stock touches 52-week low at $5.03 amid market challenges - Investing.com

Click here to get full coverage on Mind Medicine (MNMD) Gains Positive Outlook with Oppenheimer's Outperform Rating - GuruFocus

Mind Medicine (MNMD) Gains Positive Outlook with Oppenheimer's Outperform Rating  GuruFocus

Mind Medicine (MNMD) Gains Positive Outlook with Oppenheimer's Outperform Rating - GuruFocus

Click here to get full coverage on MindMed Strengthens Brain Health Pipeline with Key Technical Talent Acquisition - Stock Titan

MindMed Strengthens Brain Health Pipeline with Key Technical Talent Acquisition  Stock Titan

MindMed Strengthens Brain Health Pipeline with Key Technical Talent Acquisition - Stock Titan

Click here to get full coverage on MindMed Strengthens Executive Team with Appointment of Brandi Roberts, CPA, as Chief Financial Officer - Business Wire

MindMed Strengthens Executive Team with Appointment of Brandi Roberts, CPA, as Chief Financial Officer  Business Wire

MindMed Strengthens Executive Team with Appointment of Brandi Roberts, CPA, as Chief Financial Officer - Business Wire

Click here to get full coverage on Energy Stocks to Watch: Hess Midstream and Tetra Technologies May Fall Off a Cliff This Quarter - AInvest

Energy Stocks to Watch: Hess Midstream and Tetra Technologies May Fall Off a Cliff This Quarter  AInvest

Energy Stocks to Watch: Hess Midstream and Tetra Technologies May Fall Off a Cliff This Quarter - AInvest

Click here to get full coverage on Noteworthy Wednesday Option Activity: SLNO, FERG, MNMD - Nasdaq

Noteworthy Wednesday Option Activity: SLNO, FERG, MNMD  Nasdaq

Noteworthy Wednesday Option Activity: SLNO, FERG, MNMD - Nasdaq

Click here to get full coverage on MindMed to Report First Quarter 2025 Financial Results on May 8, 2025 - Business Wire

MindMed to Report First Quarter 2025 Financial Results on May 8, 2025  Business Wire

MindMed to Report First Quarter 2025 Financial Results on May 8, 2025 - Business Wire

Click here to get full coverage on MindMed Reports First Quarter 2025 Financial Results and Recent Business Updates - Business Wire

MindMed Reports First Quarter 2025 Financial Results and Recent Business Updates  Business Wire

MindMed Reports First Quarter 2025 Financial Results and Recent Business Updates - Business Wire

Click here to get full coverage on Why Mind Medicine Gave Investors a Powerful Buzz in May - The Motley Fool

Why Mind Medicine Gave Investors a Powerful Buzz in May  The Motley Fool

Why Mind Medicine Gave Investors a Powerful Buzz in May - The Motley Fool

Click here to get full coverage on Can MindMed's $273M War Chest Transform Anxiety Treatment? Phase 3 Trials Signal Major Momentum - Stock Titan

Can MindMed's $273M War Chest Transform Anxiety Treatment? Phase 3 Trials Signal Major Momentum  Stock Titan

Can MindMed's $273M War Chest Transform Anxiety Treatment? Phase 3 Trials Signal Major Momentum - Stock Titan

Click here to get full coverage on Mind Medicine Shareholders Approve Key Proposals at Annual Meeting - TipRanks

Mind Medicine Shareholders Approve Key Proposals at Annual Meeting  TipRanks

Mind Medicine Shareholders Approve Key Proposals at Annual Meeting - TipRanks

Click here to get full coverage on A Quick Look at Today's Ratings for Mind Medicine(MNMD.US), With a Forecast Between $18 to $55 - 富途牛牛

A Quick Look at Today's Ratings for Mind Medicine(MNMD.US), With a Forecast Between $18 to $55  富途牛牛

A Quick Look at Today's Ratings for Mind Medicine(MNMD.US), With a Forecast Between $18 to $55 - 富途牛牛

Click here to get full coverage on Psychedelic Stocks MNMD, CMPS, CYBN Show Bullish Patterns Amid Anticipated Catalysts – Impact on Crypto Sentiment - Blockchain News

Psychedelic Stocks MNMD, CMPS, CYBN Show Bullish Patterns Amid Anticipated Catalysts – Impact on Crypto Sentiment  Blockchain News

Psychedelic Stocks MNMD, CMPS, CYBN Show Bullish Patterns Amid Anticipated Catalysts – Impact on Crypto Sentiment - Blockchain News

Click here to get full coverage on Mind Medicine (MindMed) Q2 2025 Earnings Call Transcript - MarketBeat

Mind Medicine (MindMed) Q2 2025 Earnings Call Transcript  MarketBeat

Mind Medicine (MindMed) Q2 2025 Earnings Call Transcript - MarketBeat

Click here to get full coverage on Why Mind Medicine Stock Vaulted More Than 8% Higher Today - The Motley Fool

Why Mind Medicine Stock Vaulted More Than 8% Higher Today  The Motley Fool

Why Mind Medicine Stock Vaulted More Than 8% Higher Today - The Motley Fool

Click here to get full coverage on Is Mind Medicine stock a buy? - Cantech Letter

Is Mind Medicine stock a buy?  Cantech Letter

Is Mind Medicine stock a buy? - Cantech Letter

Click here to get full coverage on MindMed's LSD Anxiety Drug: Revisiting, Rethinking, But Maintaining My 'Hold' Call (MNMD) - Seeking Alpha

MindMed's LSD Anxiety Drug: Revisiting, Rethinking, But Maintaining My 'Hold' Call (MNMD)  Seeking Alpha

MindMed's LSD Anxiety Drug: Revisiting, Rethinking, But Maintaining My 'Hold' Call (MNMD) - Seeking Alpha

Click here to get full coverage on MindMed Issues Inducement Grants to New Employees - TipRanks

MindMed Issues Inducement Grants to New Employees  TipRanks

MindMed Issues Inducement Grants to New Employees - TipRanks

Click here to get full coverage on MindMed to Present at Leerink’s Global Healthcare Conference 2025 - Business Wire

MindMed to Present at Leerink’s Global Healthcare Conference 2025  Business Wire

MindMed to Present at Leerink’s Global Healthcare Conference 2025 - Business Wire

Click here to get full coverage on How does MNMD compare to its industry peers - Free Stock Movement Tracking - Jammu Links News

How does MNMD compare to its industry peers - Free Stock Movement Tracking  Jammu Links News

How does MNMD compare to its industry peers - Free Stock Movement Tracking - Jammu Links News

Click here to get full coverage on What is the dividend policy of MNMD stock - Rapid wealth multiplication - Jammu Links News

What is the dividend policy of MNMD stock - Rapid wealth multiplication  Jammu Links News

What is the dividend policy of MNMD stock - Rapid wealth multiplication - Jammu Links News

Click here to get full coverage on Breakthrough: First-Ever Phase 3 LSD Depression Trial Begins at MindMed - Stock Titan

Breakthrough: First-Ever Phase 3 LSD Depression Trial Begins at MindMed  Stock Titan

Breakthrough: First-Ever Phase 3 LSD Depression Trial Begins at MindMed - Stock Titan

Click here to get full coverage on Mind Medicine upgraded at Oppenheimer on lead asset - MSN

Mind Medicine upgraded at Oppenheimer on lead asset  MSN

Mind Medicine upgraded at Oppenheimer on lead asset - MSN

Click here to get full coverage on MindMed Appoints Matt Wiley as Chief Commercial Officer - Business Wire

MindMed Appoints Matt Wiley as Chief Commercial Officer  Business Wire

MindMed Appoints Matt Wiley as Chief Commercial Officer - Business Wire

Click here to get full coverage on MindMed Stock Skyrockets 94% Year to Date: What's Driving It? - Nasdaq

MindMed Stock Skyrockets 94% Year to Date: What's Driving It?  Nasdaq

MindMed Stock Skyrockets 94% Year to Date: What's Driving It? - Nasdaq

Click here to get full coverage on Mind Medicine Inc's Q2 2025 Earnings Call Highlights: Strong Financial Position and Strategic Advancements in MM-120 ODT Trials - AInvest

Mind Medicine Inc's Q2 2025 Earnings Call Highlights: Strong Financial Position and Strategic Advancements in MM-120 ODT Trials  AInvest

Mind Medicine Inc's Q2 2025 Earnings Call Highlights: Strong Financial Position and Strategic Advancements in MM-120 ODT Trials - AInvest

Click here to get full coverage on MindMed to Present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference - Business Wire

MindMed to Present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference  Business Wire

MindMed to Present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference - Business Wire

Click here to get full coverage on MindMed to Report Fourth Quarter and Full Year 2024 Financial Results on March 6, 2025 - Business Wire

MindMed to Report Fourth Quarter and Full Year 2024 Financial Results on March 6, 2025  Business Wire

MindMed to Report Fourth Quarter and Full Year 2024 Financial Results on March 6, 2025 - Business Wire

Click here to get full coverage on Mind Medicine's Promising Pipeline and Financial Stability Drive Buy Rating - AInvest

Mind Medicine's Promising Pipeline and Financial Stability Drive Buy Rating  AInvest

Mind Medicine Inc (MNMD)

Price Chart

Key Statistics

Technicals

About MNMD

Latest News

How do insiders feel about MNMD - 2025 Dividend Review & AI Enhanced Trading Alerts - thegnnews.com

Mind Medicine (MindMed) Stock (MNMD) Opinions on Psychedelic Therapy Political Momentum - Nasdaq

All You Need to Know About Mind Medicine MindMed (MNMD) Rating Upgrade to Buy - Yahoo Finance

Advanced Charts

Top Gainers

Top Losers